EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 3.0

Memantine as an Augmentation Therapy for Anxiety Disorders

Thomas L Schwartz, Umar A Siddiqui, Shafi Raza

Case Reports in Psychiatry · 2012 · 2012 · 1-3

DOI: 10.1155/2012/749796 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Psychiatry, 2012. Verfasst von Thomas L Schwartz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Glutamate, an excitatory neurotransmitter in the central nervous system (CNS), may play a role in the development of anxiety. Memantine partially blocks N-methyl-D-aspartate (NMDA) receptors' glutamate channels located in the CNS. This paper evaluates memantine as an augmentation therapy for treatment of anxiety.

Methods

15 consecutive partially responding anxious patients were treated with adjunctive memantine for 10 weeks. Memantine was dosed 5–20 mg/day.

Result

Memantine augmentation resulted in clinically relevant reduction in anxiety symptoms when compared to baseline. Forty percent of patients achieved remission (HAM-A ≥ 7). Memantine improved sleep quality. Mean dose was 14 mg/d (range 5–20 mg/d). Typical adverse events included nausea and headache.

Conclusion

The NMDA receptor antagonist memantine may be an effective augmentation therapy in patients with treatment-resistant anxiety.

Autor:innen und Institutionen

  • Department of Psychiatry, SUNY Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA.

Zitieren

APA

Schwartz, T. L., Siddiqui, U. A., & Raza, S. (2012). Memantine as an Augmentation Therapy for Anxiety Disorders. Case Reports in Psychiatry, 2012, 1-3. https://doi.org/10.1155/2012/749796

Vancouver

Schwartz TL, Siddiqui UA, Raza S. Memantine as an Augmentation Therapy for Anxiety Disorders. Case Reports in Psychiatry. 2012;2012:1-3. doi:10.1155/2012/749796

BibTeX
@article{Schwartz2012,
  author = {Schwartz, Thomas L and Siddiqui, Umar A and Raza, Shafi},
  title = {Memantine as an Augmentation Therapy for Anxiety Disorders},
  journal = {Case Reports in Psychiatry},
  year = {2012},
  volume = {2012},
  pages = {1--3},
  doi = {10.1155/2012/749796}
}
Kostenlos starten →